Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Lupin Limited (NSE: LUPIN)

 
LUPIN Technical Analysis
2
As on 23rd Apr 2024 LUPIN SHARE Price closed @ 1580.05 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1223.29 & Sell for SHORT-TERM with Stoploss of 1608.21 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

LUPINSHARE Price

Open 1602.00 Change Price %
High 1614.00 1 Day -23.60 -1.47
Low 1577.45 1 Week -31.40 -1.95
Close 1580.05 1 Month -28.20 -1.75
Volume 849166 1 Year 884.90 127.30
52 Week High 1119.25 | 52 Week Low 590.25
 
LUPIN CURRENT MONTH FUTURE
Close 1599.15
Contracts Traded 4442950
Open Intrest 4136100
Change In O.I -26.75 %
Lot Size 850
LUPIN CURRENT MONTH OPTION
Most Active Call 1600.00
Most Active put 1580.00
Highest O.I Buildup Call 1700.00
Highest O.I Buildup Put 1560.00
Expiry Date 2024-04-25
LUPIN ALL MONTHS OPTIONS
For All LUPIN Options Click Here
 
NSE INDIA Most Active Stocks
IDEA 14.40 11.63%
YESBANK 25.65 1.79%
SUZLON 41.85 2.45%
EASEMYTRIP 47.15 4.89%
RAMASTEEL 13.65 6.64%
TTML 84.90 9.27%
NHPC 89.75 1.36%
IRFC 147.75 2.53%
SAIL 152.25 2.59%
ZOMATO 187.45 -3.05%
 
NSE INDIA Top Gainers Stocks
SMARTLINK 212.70 20.00%
TEJASNET 1088.25 20.00%
OAL 383.55 19.99%
UMANGDAIRY 100.95 19.96%
ASHIMASYN 21.45 17.21%
LUXIND 1332.00 15.81%
SUDARSCHEM 717.05 13.87%
COCHINSHIP 1251.95 13.29%
INDRAMEDCO 276.25 12.66%
BSE 3199.85 12.22%
 
NSE INDIA Top Losers Stocks
ANUP 1827.25 -49.19%
ASTERDM 399.50 -22.18%
TEMBO 203.10 -10.76%
KMSUGAR 40.40 -9.92%
PALASHSECU 135.30 -9.77%
LYPSAGEMS 6.75 -6.25%
TPLPLASTEH 94.80 -5.77%
M&MFIN 263.45 -5.52%
SOLARA 547.60 -5.46%
KICL 4276.75 -5.23%
 
 
LUPIN
Daily Charts		 LUPIN
Intraday Charts		 Whats New @
Bazaartrend		 LUPIN
Free Analysis
 
LUPIN Important Levels Intraday
RESISTANCE1650.48
RESISTANCE1627.89
RESISTANCE1613.93
RESISTANCE1599.97
SUPPORT1560.13
SUPPORT1546.17
SUPPORT1532.21
SUPPORT1509.62
 
LUPIN Target April 2024
Share
4th UP Target2263.83
3rd UP Target2058.81
2nd UP Target1932.08
1st UP Target1805.35
1st DOWN Target1443.75
2nd DOWN Target1317.02
3rd DOWN Target1190.29
4th DOWN Target985.27
 
LUPIN Weekly Target
4th UP Target1742.08
3rd UP Target1679.69
2nd UP Target1641.13
1st UP Target1602.57
1st DOWN Target1492.53
2nd DOWN Target1453.97
3rd DOWN Target1415.41
4th DOWN Target1353.02
 
LUPIN Target2024
4th UP Target2717.81
3rd UP Target2270.47
2nd UP Target1993.96
1st UP Target1717.45
1st DOWN Target928.45
2nd DOWN Target651.94
3rd DOWN Target375.43
4th DOWN Target-71.91
 
 
LUPIN Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
 Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 35.09 Sideways
MFI (14) MFI is 34.49 Sideways
CCI (20) CCI is -80.13 Sideways
WILLIAM %R (14) William %R is -40.54 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 663.86
10 Day Avg Volume Traded -7.53 % Less then 10 Day Average Volume
 
LUPIN Other Details
Segment EQ
Market Capital 426989584384.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
LUPIN Address
LUPIN
 
LUPIN Latest News
 
Your Comments and Response on Lupin Limited
 
LUPIN Business Profile
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, active pharmaceutical ingredients (APIs), and specialty products in India, the United States, Japan, and internationally. It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, anti-tuberculosis, and cephalosporin, as well as digital therapeutics platform for doctors and patients. The company is also involved in the provision of biosimilar and over-the-counter products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. It has a licensing, development, and commercialization agreement with Boehringer Ingelheim for Lupin's MEK inhibitor compound (LNP3794) as a potential targeted therapy for patients with cancers. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India. Address: Kalpataru Inspire, Mumbai, India, 400055
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service